(Q36175304)

12 August 2017

Sildenafil improves walk distance in idiopathic pulmonary fibrosis (English)

1 reference

12 August 2017

1 reference

2

Kevin J Anstrom

1 reference

12 August 2017

Harold R Collard

1

1 reference

12 August 2017

Marvin I Schwarz

series ordinal

3

1 reference

12 August 2017

David A Zisman

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

12 August 2017

3

1 reference

inferred from page(s)

published in

Chest

1 reference

12 August 2017

131

1 reference

12 August 2017

3

1 reference

12 August 2017

897-899

1 reference

Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Brain natriuretic peptide is a prognostic parameter in chronic lung disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Effects of Aerosol vs IV UT-15 on Prostaglandin H2 Analog-Induced Pulmonary Hypertension in Sheep

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098039

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

5 December 2018

1 reference

12 December 2020

A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease

1 reference

12 December 2020

Identifiers

DOI

10.1378/CHEST.06-2101

1 reference

12 August 2017

1 reference

12 August 2017

1 reference